Fraboc: The Retired Breast Cancer Risk Tool, Explained (2026 Guide)

Fraboc is one of those words that looks like a typo, a brand name, or a medical abbreviation you were never taught. If you typed it into Google, you probably saw a handful of thin articles that say almost nothing useful — and you’re still wondering what it actually means.

Here’s the short answer: fraboc stood for FRA-BOC — “Familial Risk Assessment – Breast and Ovarian Cancer.” It was an online clinical tool created by Cancer Australia that helped doctors and nurses estimate a woman’s risk of developing breast or ovarian cancer based on her family history. It was never a medicine, never a test you take at home, and never a diagnosis. And today, it no longer exists: the tool has been retired, replaced by newer risk-assessment models.

This guide explains what FRA-BOC was, how it worked, why it was retired, what replaced it, and what you should actually do today if you’re concerned about your own family history. One important note up front: this is general information, not medical advice. If you have questions about your personal risk, talk to your doctor.

What Does Fraboc Mean?

Fraboc isn’t a word in any dictionary. It’s an acronym — FRA-BOC — that people write in lowercase when they hear it spoken or see it in a document without context. The letters break down like this:

Letters	Meaning
FRA	Familial Risk Assessment
B	Breast
OC	Ovarian Cancer

So the full name was “Familial Risk Assessment – Breast and Ovarian Cancer.” It was an online tool, hosted on the Cancer Australia website, designed to help health professionals — mainly general practitioners (GPs), practice nurses, and other primary-care clinicians — work through a woman’s family history of breast and ovarian cancer and estimate her risk level.

If you came across “fraboc” in an old GP handout, a referral letter, or a health pamphlet, that’s almost certainly where it came from. It was part of Australia’s national effort to get family-history risk assessment right in primary care.

What Was FRA-BOC, Exactly?

FRA-BOC was a decision-support tool, not a test. Think of it like a structured checklist with a built-in calculator. A doctor would sit with a patient, walk through her family history of breast and ovarian cancer, and the tool would sort her into a risk category.

Here is how it worked, step by step:

1. The doctor collected a detailed family history. This meant mapping cancer cases on both sides of the family — mother and father — including who was diagnosed, with which cancer, and at what age.
2. The answers were entered into the online tool. The tool asked structured questions: any first-degree relatives with breast cancer before age 50? Any ovarian cancer anywhere in the family? Breast cancer in a male relative? Ashkenazi Jewish ancestry?
3. The tool estimated a risk category. Based on Australian clinical guidelines, it placed the woman into one of three categories: at or slightly above average risk, moderately increased risk, or potentially high risk.
4. It guided the next step. Women in the lower categories were generally managed in primary care with standard screening. Women flagged as potentially high risk were identified for referral to a family cancer clinic for further assessment, genetic counselling, and possibly genetic testing.

The tool also provided an estimation of risk for women not yet affected by cancer — it was a prevention and planning tool, helping doctors decide who needed extra screening and who didn’t.

What Fraboc Was NOT

This is where a lot of confusion happens, so let’s be precise. FRA-BOC was:

• NOT a diagnostic test. It couldn’t tell you whether you had cancer or would definitely get it. It estimated risk based on family history.
• NOT a genetic test. It didn’t analyse your DNA. It asked about your relatives.
• NOT a home-use tool. It was built for health professionals to use during a consultation.
• NOT a treatment or medicine. It produced advice and referrals, not prescriptions.
• NOT still available. The online tool has been retired.

If a website claims fraboc was a drug, a supplement, or a home test kit, that site is wrong — that’s one of the fastest ways to spot an unreliable source.

FRA-BOC at a Glance

Fact	Detail
Full name	Familial Risk Assessment – Breast and Ovarian Cancer
Developed by	Cancer Australia (the Australian government’s national cancer agency)
Made for	Health professionals (GPs, nurses) in primary care
Purpose	Estimate breast/ovarian cancer risk from family history
Based on	Structured family-history questions matched to clinical guidelines
Output	A risk category (average / moderately increased / potentially high) plus referral advice
What it wasn’t	A diagnosis, a genetic test, or a home tool
Status today	Retired — no longer available online

The Timeline: What Happened to FRA-BOC

The tool’s story has a clear shape, even if most websites covering it skip the history entirely:

Phase	What happened
Creation	Cancer Australia developed FRA-BOC to help GPs assess family-history risk consistently, so advice didn’t depend on which doctor you happened to see.
Active clinical use	The tool lived on the Cancer Australia website and was used in primary-care consultations to sort women into risk categories and guide referrals to family cancer clinics.
Retirement	The online tool was discontinued. Like many early digital health tools, it aged out as guidelines, technology, and risk models moved forward.
Replacement era	Newer risk-assessment models took its place — most notably iPrevent, developed by the Peter MacCallum Cancer Centre, along with established international models like the Gail model and BOADICEA/CanRisk.

You won’t find FRA-BOC live on Cancer Australia’s website anymore. If a doctor today mentions “familial risk assessment,” they mean the same idea — but they will be using a current tool, not fraboc.

What Replaced FRA-BOC

The retirement of FRA-BOC didn’t leave a gap — it was overtaken by better tools. Here’s what doctors use now:

Tool	Developed by	What it does
iPrevent	Peter MacCallum Cancer Centre (Australia)	An online breast cancer risk assessment and risk-management tool. It estimates a woman’s individual risk and gives personalised recommendations on screening, lifestyle, and prevention options.
Gail model (BCRAT)	US National Cancer Institute	One of the oldest widely used breast cancer risk models, estimating 5-year and lifetime risk from factors like age, family history, and reproductive history.
BOADICEA / CanRisk	University of Cambridge	A comprehensive model that can incorporate detailed family history and genetic test results to estimate risk of breast and ovarian cancer.

The key upgrade these tools offer over the original FRA-BOC is individual risk estimation with tailored management advice — not just a broad category, but guidance on what screening and prevention steps make sense for that specific woman.

Why People Still Search “Fraboc” Today

FRA-BOC is gone, but searches for “fraboc” keep going. The most common reasons:

• Old paperwork. People find the word in old GP handouts, referral letters, or health pamphlets and want to know what it meant.
• Word-of-mouth. Someone was told “your doctor might use the fraboc assessment” years ago and is only now looking it up.
• Thin content. The articles currently ranking for the term are short, vague, and often wrong — so searchers bounce from one to the next looking for a real answer. (If that’s you, welcome — this is the real answer.)
• Family-history anxiety. Behind most “fraboc” searches is a real person with a real worry: breast or ovarian cancer in the family, and a question about what to do.

That last reason is the one that matters. The tool may be retired, but the question it answered — “is my family history something to worry about?” — is as relevant as ever. So let’s answer that.

Understanding the Risk Categories

FRA-BOC sorted women into three broad risk levels. Modern guidelines still think in these terms, so they’re worth understanding:

Category	What it means	Typical next step
1 — At or slightly above average risk	Most women fall here. Family history includes little or no breast/ovarian cancer, or only low-concern patterns (e.g. one first-degree relative diagnosed at age 50 or older).	Standard population screening; reassurance.
2 — Moderately increased risk	A stronger pattern — for example, one first-degree relative diagnosed before age 50, or two relatives on the same side of the family.	Earlier or more frequent screening, discussed with the GP.
3 — Potentially high risk	Concerning features: multiple relatives with breast or ovarian cancer on one side of the family, diagnosis before age 40, breast and ovarian cancer in the same woman, breast cancer in a male relative, Ashkenazi Jewish ancestry, or a known BRCA mutation in the family.	Referral to a family cancer clinic for genetic counselling and possible genetic testing.

Important: risk categories describe populations, not certainties. Most women in Category 2 never develop breast cancer; many cancers occur in women with no family history at all. Categories guide screening decisions — they don’t predict your personal future.

Red Flags in Your Family History

You don’t need the old FRA-BOC tool to spot a family history that deserves a proper conversation with your doctor. These are the patterns clinicians take seriously:

• Several close relatives with breast or ovarian cancer on the same side of the family (mother’s side or father’s side — both count).
• Breast cancer diagnosed at a young age, especially before 40.
• Ovarian cancer anywhere in the family — this is a significant signal, even though many people overlook it.
• Breast and ovarian cancer in the same woman, or cancer in both breasts.
• Breast cancer in a male relative — rare, and a strong marker of inherited risk.
• A known BRCA1 or BRCA2 mutation (or another high-risk gene) in the family.
• Ashkenazi Jewish ancestry combined with breast or ovarian cancer in the family, because certain founder mutations are more common.

One pattern on this list doesn’t automatically mean you’re high risk — doctors look at the whole picture. But any of them is a good reason to raise the topic at your next appointment rather than Googling in circles.

What To Do Now: Practical Next Steps

Forget the retired tool. Here’s the modern, practical version of what FRA-BOC was trying to achieve for you:

1. Write down your family history. Before your appointment, list relatives with breast, ovarian, or related cancers (prostate and pancreatic cancers can also be relevant), noting their age at diagnosis and which side of the family. Both sides matter — risk genes can come from your father too.
2. Bring it to your GP. Ask directly: “Can we review my family history of breast and ovarian cancer?” GPs are trained for this conversation, and family cancer clinics exist precisely for the next step.
3. Ask about current risk tools. If your doctor wants a formal estimate, tools like iPrevent or the models above are what they’ll reach for — not FRA-BOC.
4. Don’t skip standard screening. Whatever your family history, follow your country’s screening guidelines (mammograms from the recommended age) unless your doctor advises otherwise. Family history adds to screening; it never replaces it.
5. Know about family cancer clinics. If your history looks concerning, your GP can refer you to a family cancer clinic, where genetic counsellors take a detailed pedigree, discuss whether genetic testing (e.g. for BRCA1/BRCA2) makes sense, and plan tailored screening. The visit is about information and options, not alarm.
6. Focus on what you can control. Some risk factors are modifiable: maintaining a healthy weight, limiting alcohol, staying physically active, and breastfeeding if possible are all associated with lower breast cancer risk. They’re not guarantees, but they’re the part of the equation you own.

And when you meet an unfamiliar health term in the future — on a handout, a referral, or a search result — use the same verify-first habit we apply to decoding medical names like metronidasool or untangling mystery words like mmsbre. Check it against an authoritative source (Cancer Australia, your GP, a family cancer clinic), not against thin content farms. We use that same approach for non-health mysteries too — like our Brandihomes.com guide for decoding home-brand names.

Frequently Asked Questions

What does fraboc stand for?

Fraboc stands for FRA-BOC — “Familial Risk Assessment – Breast and Ovarian Cancer.” It was an online tool by Cancer Australia that helped health professionals assess a woman’s breast and ovarian cancer risk from her family history.

Is fraboc still available?

No. FRA-BOC has been retired and is no longer available online. It has been replaced by newer risk-assessment tools such as iPrevent (from the Peter MacCallum Cancer Centre), the Gail model, and BOADICEA/CanRisk.

Was fraboc a cancer test?

No. It was a risk-assessment aid, not a diagnostic test or a genetic test. It estimated risk categories from family-history information entered by a doctor — it could not diagnose cancer or analyse DNA.

Who was FRA-BOC made for?

It was designed for health professionals — mainly GPs and practice nurses — to use during consultations with women who were not affected by cancer, to guide screening and referral decisions.

What should I use instead of FRA-BOC?

Talk to your GP. Current options include the iPrevent tool and established risk models like the Gail model and BOADICEA/CanRisk, used alongside referral to a family cancer clinic when the history warrants it.

I have breast cancer in my family — should I be worried?

A family history raises the question; it doesn’t answer it. Many women with affected relatives never develop cancer, and most breast cancers occur in women with no family history. The right move is a calm, factual review with your GP — bring the details (who, which cancer, what age) and let a professional assess the pattern. This article is general information, not medical advice about your situation.

Does family history on my father’s side count?

Yes — absolutely. Breast and ovarian cancer risk genes (including BRCA1 and BRCA2) can be inherited from either parent. Doctors always assess both sides of the family.

The Bottom Line

Fraboc — FRA-BOC, “Familial Risk Assessment – Breast and Ovarian Cancer” — was Cancer Australia’s online tool for helping GPs turn a messy family history into a clear risk category and a sensible next step. It did its job, aged out, and was retired in favour of better tools like iPrevent and the Gail model.

But the question it was built to answer hasn’t retired: does my family history put me at higher risk, and what should I do about it? The modern answer is simpler than the acronym: write down your family history, bring it to your GP, keep up with standard screening, and ask for a family cancer clinic referral if the pattern looks concerning. That’s the FRA-BOC workflow, minus the acronym — and it’s available to you today.

Medical disclaimer: This article is for general information only and is not medical advice. It does not replace professional diagnosis or treatment. If you are concerned about breast or ovarian cancer risk, please speak with your doctor or a qualified health professional.